Published in J Infect Dis on September 01, 1998
Real-time PCR in virology. Nucleic Acids Res (2002) 6.71
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86
Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol (2001) 1.82
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol (2001) 1.45
Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J Clin Microbiol (2000) 1.39
Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol (2002) 1.38
Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J Clin Microbiol (2001) 1.32
Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol (2000) 1.32
Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol (2013) 1.28
Multi-Site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. J Mol Diagn (2009) 1.28
Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol (2000) 1.24
Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn (2000) 1.06
Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol (2003) 1.05
Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation. J Clin Microbiol (2000) 1.04
Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol (2003) 1.03
Cytomegalovirus and inflammatory bowel disease: is there a link? World J Gastroenterol (2006) 0.94
Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay. J Clin Microbiol (2003) 0.93
Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus. J Clin Microbiol (2004) 0.92
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients. J Clin Microbiol (2002) 0.91
CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays. BMC Infect Dis (2001) 0.85
A Model for HCMV Infection in Immunosuppressed Patients. Math Comput Model (2009) 0.83
Time profile of viral DNA in aqueous humor samples of patients treated for varicella-zoster virus acute retinal necrosis by use of quantitative real-time PCR. J Clin Microbiol (2013) 0.80
Long-term persistence of immunoglobulin A (IgA) and IgM antibodies against human cytomegalovirus in solid-organ transplant recipients. Clin Diagn Lab Immunol (1999) 0.75
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med (1999) 3.45
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Acute renal failure. Lancet (1995) 3.14
A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant (2010) 2.69
MELD Exceptions and Rates of Waiting List Outcomes. Am J Transplant (2011) 2.47
Addressing geographic disparities in liver transplantation through redistricting. Am J Transplant (2013) 2.46
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis (2001) 2.16
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
Delayed graft function in the kidney transplant. Am J Transplant (2011) 2.06
OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant (2014) 2.01
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant (2012) 1.90
A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant (2007) 1.88
Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant (2009) 1.83
Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol (2005) 1.78
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation (2000) 1.72
Enteroviral meningitis in infancy: potential role for polymerase chain reaction in patient management. Pediatrics (1994) 1.70
An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis (1992) 1.69
Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet (1995) 1.68
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation (1999) 1.62
OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant (2014) 1.59
Cerebrospinal fluid protein concentration in pediatric patients: defining clinically relevant reference values. Arch Pediatr Adolesc Med (2000) 1.59
Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant (2001) 1.56
Enhanced neutrophil respiratory burst as a biological marker for manipulation forces: duration of the effect and association with substance P and tumor necrosis factor. J Manipulative Physiol Ther (1992) 1.54
Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J (1994) 1.53
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant (2006) 1.52
Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients. Bone Marrow Transplant (2006) 1.50
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis (2001) 1.49
Antibiotic-induced lysis of enterococci. J Clin Invest (1981) 1.49
Bk virus: a clinical review. Clin Infect Dis (2001) 1.48
BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant (2010) 1.43
Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients. J Clin Microbiol (1992) 1.43
Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin Infect Dis (1995) 1.40
Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol (1994) 1.36
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int (1991) 1.35
BK virus infection in transplant recipients: an overview and update. Am J Transplant (2006) 1.30
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis (1990) 1.29
Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation (1995) 1.28
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation (1999) 1.27
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1997) 1.24
Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus. J Med Virol (1987) 1.23
Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage. Am J Transplant (2008) 1.22
Cytomegalovirus encephalitis. Ann Intern Med (1996) 1.21
Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR. J Clin Microbiol (1997) 1.19
Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol (1993) 1.18
Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis (1993) 1.16
Evaluation of a genetically engineered cell line and a histochemical beta-galactosidase assay to detect herpes simplex virus in clinical specimens. J Clin Microbiol (1993) 1.14
Identification of two forms of an endogenous murine retroviral env gene linked to the Rmcf locus. J Virol (1987) 1.13
Granulomatous hepatitis associated with cat scratch disease. Lancet (1988) 1.12
Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. Kidney Int (1990) 1.12
Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol (1995) 1.10
Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab (1986) 1.10
Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int (1993) 1.10
Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens. J Clin Microbiol (1999) 1.09
Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am J Med (1998) 1.09
Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests. J Infect Dis (1984) 1.08
OPTN/SRTR 2012 Annual Data Report: heart. Am J Transplant (2014) 1.08
Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis (1995) 1.07
Preparation of urine samples for use in commercial latex agglutination tests for bacterial antigens. J Clin Microbiol (1985) 1.07
OPTN/SRTR 2012 Annual Data Report: lung. Am J Transplant (2014) 1.07
Comparison of the Oxoid Signal blood culture system with supplemented peptone broth in a pediatric hospital. J Clin Microbiol (1989) 1.07
Methicillin-resistant Staphylococcus aureus bacteremia in children. Pediatr Infect Dis (1986) 1.06
Comparison of automated Difco ESP blood culture system with biphasic BBL Septi-Chek system for detection of bloodstream infections in pediatric patients. J Clin Microbiol (1995) 1.04
Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation (2001) 1.03
PCR amplification and phylogenetic analysis of groESL operon sequences from Ehrlichia ewingii and Ehrlichia muris. J Clin Microbiol (2000) 1.02
Optimizing recovery of cytomegalovirus in the shell vial culture procedure. Diagn Microbiol Infect Dis (1991) 1.01
Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int (1992) 1.01
The epidemiology of influenza B in a rural setting in 1977. Am J Epidemiol (1979) 1.00
Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr (1995) 0.99
Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am J Pathol (1991) 0.99
Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin. J Exp Med (1990) 0.99